Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BIO

BIO-RAD LABORATORIES, INC.

Technology · Scientific & Technical Instruments

$377.69Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

BIO-RAD LABORATORIES, INC. shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -0% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -0% YoY in Q2 FY2026

Pipeline evidence · 0d ago

BIO's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BIO.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BIO earnings analysis

Reported figures for BIO-RAD LABORATORIES, INC. — research only, not investment advice.

Revenue YoY
-0.1%
EPS YoY
+18.7%

Latest Intelligence

Updated

What happened recently for BIO-RAD LABORATORIES, INC. (BIO) — events, not interpretation.

Event
Reported Q2 2026 revenue -0% YoY.
Also
Last session September 28, 2026 at $377.69.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

BIO-RAD LABORATORIES, INC. (BIO)

Technology · Scientific & Technical Instruments

Investment Snapshot above is the primary AlphaOS analysis for BIO-RAD LABORATORIES, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Technology
Market cap:
$10.45B
Revenue:
$651.00M

BIO earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow BIO-RAD LABORATORIES, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.